Prenetics Global Ltd (PRE) News & EventsPREPrenetics Global Ltd

Prenetics Secures Around $1B Financing for IM8

David Beckham and Prenetics' IM8 has lined up around $1B in growth financing from General Catalyst, Swetha Gopinath of Bloomberg reports, citing a statement. General Catalyst's Customer Value Fund will finance up to 70% of IM8's marketing spend and receive a share of income, capped at a certain level, according to Bloomberg. IM8, which sells nutritional supplements, is expected to reach $300M in annualized run-rate revenue by the end of 2026, according to the statement, Bloomberg adds. Prenetics is also raising its full-year 2026 IM8 revenue guidance to $210M-$220M from $190M-$210M, the second increase this year, according to Bloomberg.

IM8 Q1 Revenue Grows Nearly 6x Year-over-Year

Danny Yeung, CEO and co-founder, commented: "The momentum behind IM8 is extraordinary. Q1 2026 was a defining quarter - IM8 revenue grew nearly 6x year-over-year and 23.1% sequentially over Q4 2025, and our quarterly subscription strategy delivered a step-change in customer economics. The acceleration has continued into Q2 2026: April delivered approximately $14.0 million in IM8 monthly revenue, an 18.6% increase over March, and IM8 monthly revenue is tracking to reach approximately $15.5 million in May, implying annualized recurring revenue of approximately $186 million."

IM8 Raises 2026 Revenue Guidance to $190M-$210M

The company said, "Based on this trajectory, we currently expect Q2 2026 revenues of approximately $46 million to $48 million, with IM8 contributing approximately $44 million to $46 million - representing approximately 33% sequential quarterly growth in IM8 revenue. We are also raising our full-year 2026 IM8 revenue guidance to $190 million to $210 million, from our prior range of $180 million to $200 million. The strength of our underlying unit economics, the global pull we are seeing from consumers across more than 40 markets, and the upside in new marketing channels gives us strong conviction. Looking ahead, I am especially excited about our product roadmap. In Q4 2026, IM8 plans to launch new offerings in three meaningful categories with very large addressable markets - hydration, creatine and kids' gummies - extending the brand into high-growth segments and giving our global community more ways to make IM8 part of their daily lives. Each of these launches is grounded in the same standard that defines IM8: world-class science, premium ingredients and genuine consumer demand. What we have built with David Beckham, our elite roster of athlete partners, and our world-class scientific advisory board is becoming a category-defining global health brand. Q1 proved the model. Q2 is proving the acceleration. The rest of 2026 will demonstrate the scale of the opportunity ahead."